ODTX insider trading

Odyssey Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
79
Last 90 days
79
Buys / sells
11% / 4%
Market cap

ODTX insider activity at a glance

FilingIQ has scored 79 insider transactions for ODTX since May 7, 2026. The most recent filing in our index is dated May 11, 2026.

Across the full history, 9 open-market purchases and 3 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ODTX insider trades is 59.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest ODTX Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Top insiders trading ODTX

Frequently asked

How many insider trades does FilingIQ track for ODTX?
FilingIQ tracks 79 Form 4 insider transactions for ODTX (Odyssey Therapeutics, Inc.), covering filings from May 7, 2026 onwards. 79 of those were filed in the last 90 days.
Are ODTX insiders net buyers or net sellers?
Across the full Form 4 history for ODTX, 9 transactions (11%) were open-market purchases and 3 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ODTX insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every ODTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.